Kashishipr

DECEMBER 28, 2021

Three pharmaceutical companies, including Enzon Pharmaceuticals, Micromet AG, and Cambridge Antibody Technology (now acquired by AstraZeneca), in September 2003 announced signing a non-exclusive cross-license agreement. To be specific, any aspect of the invention not covered in the claims isn’t considered to be protected.

IP 105

IP Patent Invention Licensing 105

SpicyIP

AUGUST 14, 2023

Other Posts Timelines under Rule 138 of Patent Rules are to be interpreted strictly and there cannot be any leeway under Rule 49.6 of PCT Regulations, says Delhi High Court The DHC ruled that timelines for filing national phase applications cannot be extended, in light of India’s reservation to the PCT Regulations on this.

Trademark 98

Trademark Registration Art Reporting 98

SpicyIP

MAY 15, 2023

The petitioner is the sole registered proprietor and user of the “Maxgalin” mark, a Schedule H drug, since 2005. 1 applied for the registration of “MGalin” in 2018 with false user data of 7th January 2003, to which the respondent failed to adduce any evidence to rebut the assertion.

Trademark 104

Trademark Registration Cease and Desist IP 104